Alzheimer's

Gottlieb announces ‘significant modernization’ for FDA regulation of dietary supplements

On the same day the FDA warned companies against hawking dietary supplements for Alzheimer's disease, Commissioner Scott Gottlieb announced "one of the most significant modernizations of dietary supplement regulation and oversight in 25 years." Three out of every four Americans take dietary supplements regularly, contributing to an industry worth more than $40 billion.